Intracellular levels of GSDMD are significantly increased during the early stages of pancreatic cancer development, but further investigation is required to determine if GSDMD levels are elevated in bodily fluids or the systemic circulation. This evidence concerns the gene GSDMD and pancreatic neoplasm.